Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF ‐like conformation of Tau protein
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The mechanistic relationship between amyloid β1-42 (Aβ1-42) and the alteration of Tau protein are debated. We investigated the effect of Aβ1-42 monomers and oligomers on Tau, using mice expressing wild-type human Tau that do not spontaneously develop Tau pathology. After intraventricular injection of Aβ1-42, mice were sacrificed after 3 h or 4 days. The short-lasting treatment with Aβ monomers, but not oligomers, showed a conformational PHF-like change of Tau, together with hyperphosphorylation. The same treatment induced increase in concentration of GSK3 and MAP kinases. The inhibition of the kinases rescued the Tau changes. Aβ monomers increased the levels of total Tau, through the inhibition of proteasomal degradation. Aβ oligomers reproduced all the aforementioned alterations only after 4 days of treatment. It is known that Aβ1-42 monomers foster synaptic activity. Our results suggest that Aβ monomers physiologically favor Tau activity and dendritic sprouting, whereas their excess causes Tau pathology. Moreover, our study indicates that anti-Aβ therapies should be targeted to Aβ1-42 monomers too.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · cited 1×
“In previous reports, the capability of A b 1-42 to induce Tau aggregation was studied in mice expressing mutant human Tau, models of tauopathies (Lewis et al. , 2001; Oddo et al. , 2006; Rhein et al. , 2009; Nisbet et al. , 2015).”
BackgroundPicomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 1×
“Picomolar concentrations of A b 1-42 foster synaptic activity (Puzzo et al. , 2008).”
BackgroundSelf-citationHyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
GSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
Tau Aggregation and Its Interplay with Amyloid-β
Nisbet, R. M., Polanco, J.-C., Ittner, L. M., & Götz, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1371-2 · Cited by 359 · cited 2×
“In previous reports, the capability of A b 1-42 to induce Tau aggregation was studied in mice expressing mutant human Tau, models of tauopathies (Lewis et al. , 2001; Oddo et al. , 2006; Rhein et al. , 2009; Nisbet et al. , 2015).”
GSK3 and tau: Two convergence points in Alzheimer’s disease
Hernandez, F., Lucas, J. J., & Avila, J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129025 · Cited by 359
Decreased cerebrospinal fluid Aβ 42 correlates with brain atrophy in cognitively normal elderly
Fagan, A. M., Head, D., Shah, A. R., Marcus, D., Mintun, M., Morris, J. C., & Holtzman, D. M. (2009) · Annals of Neurology · doi:10.1002/ana.21559 · Cited by 327 · cited 1×
“Its concentration in interstitial fluid is proportional to the level of global brain function (Fagan et al. , 2009).”
BackgroundConformational change as one of the earliest alterations of tau in Alzheimer's disease
Weaver, C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00157-3 · Cited by 310 · cited 3×
“MC1 is a conformation-dependent antibody that recognizes an early pathological Tau conformation (Weaver et al. , 2000).”
Bolmont, T., Clavaguera, F., Meyer-Luehmann, M., Herzig, M. C., Radde, R., Staufenbiel, M., Lewis, J., Hutton, M., Tolnay, M., & Jucker, M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070403 · Cited by 281 · cited 2×
“…(cid:1) ın et al. , 2014) altering its capacity to bind tubulin; (ii) A b alters the proteasomal degradation of Tau, increasing its concentration in free state (Oddo et al. , 2009); (iii) A b intracellular aggregates have a nucleation effect on Tau (Guo et al. , 2006; Bolmont et al. , 2007).”
BackgroundAndo, K., Maruko-Otake, A., Ohtake, Y., Hayashishita, M., Sekiya, M., & Iijima, K. M. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005917 · Cited by 105 · cited 1×
“The lack of phosphorylation at this site is not in agreement with literature data reporting that levels of Ser262 phosphorylation were increased by A b 1-42, but in those studies were not used A b monomers (Qureshi et al. , 2013; Ando et al. , 2016).”
Genetically Altering Aβ Distribution from the Brain to the Vasculature Ameliorates Tau Pathology
Oddo, S., Caccamo, A., Cheng, D., & LaFerla, F. M. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00194.x · Cited by 33 · cited 1×
“…(cid:1) ın et al. , 2014) altering its capacity to bind tubulin; (ii) A b alters the proteasomal degradation of Tau, increasing its concentration in free state (Oddo et al. , 2009); (iii) A b intracellular aggregates have a nucleation effect on Tau (Guo et al. , 2006; Bolmont et al. , 2007).”
Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation
Piras, S., Furfaro, A. L., Piccini, A., Passalacqua, M., Borghi, R., Carminati, E., Parodi, A., Colombo, L., Salmona, M., Pronzato, M. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.002 · Cited by 27 · cited 1×
“We previously showed that they increase receptor for advanced glycation end products (RAGE) expression (Piras et al. , 2014), BACE1 protein levels (Piccini et al. , 2012), and inhibit lysosomal activity, through the activation of the nuclear factor (NF)- j B pathway (Guglielmotto et al. , 2012).”
Self-citation
Cited by
Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 275
Caruso, G., Caraci, F., & Jolivet, R. B. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.004 · Cited by 110
“showed that Aβ monomers physiologically favor tau protein activity and dendritic sprouting, whereas their excess causes tau pathology (Manassero et al., 2016).”
Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
DeVos, S. L., Corjuc, B. T., Commins, C., Dujardin, S., Bannon, R. N., Corjuc, D., Moore, B. D., Bennett, R. E., Jorfi, M., Gonzales, J. A., et al. (2018) · Brain · doi:10.1093/brain/awy117 · Cited by 106
Epigenetics of chronic inflammatory diseases
Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79
“In addition, evidence for altered editing of miRNAs (by modification of adenosine to inosine) has been found in AD.(101) Currently, the field lacks studies in which the observed differences in AD miRNAs have been independently validated and/or which correlate specific miRNA expression/function with clinical phenotype.”
BackgroundInfluentialThe Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer’s Disease
Hoxha, E., Lippiello, P., Zurlo, F., Balbo, I., Santamaria, R., Tempia, F., & Miniaci, M. C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00396 · Cited by 58
“In accordance with this hypothesis, recent evidence shows that, in transgenic mice expressing the human tau protein, injection of Aβ1–42 monomers can induce tau hyperphosphorylation (Manassero et al., 2016).”
Background
Metadata
- Authors
- Manassero, G., Guglielmotto, M., Zamfir, R., Borghi, R., Colombo, L., Salmona, M., Perry, G., Odetti, P., Arancio, O., Tamagno, E., & Tabaton, M.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2016-07-12
- Volume
- 15
- Issue
- 5
- Pages
- 914-923
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W2469385416
- Cited by
- 32
- References
- 13
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.